INS and type 2 diabetes mellitus: Similarly, in a cohort of 2864 women with T2DM, patients taking insulin sensitizers had less decline in usual walk speed than those not taking insulin sensitizers (−1.07 vs. −0.10 m/s), without significant differences in grip strength [59].